Combining functional and structural brain magnetic resonance imaging in Huntington disease

Journal of Computer Assisted Tomography

Volumn 31, Issue 4, 2007, Pages 574-580

  Gavazzi, Cinzia ^a   Nave, Riccardo Della ^a   Petralli, Raffaele ^a   Rocca, Maria Assunta ^b   Guerrini, Laura ^a   Tessa, Carlo ^a   Diciotti, Stefano ^a   Filippi, Massimo ^b   Piacentini, Silvia ^a   Mascalchi, Mario ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Cortical reorganization; Functional magnetic resonance; Huntington disease; Voxel based morphometry

Indexed keywords

BRAIN; MAGNETIC RESONANCE IMAGING; MAGNETISM; NEURODEGENERATIVE DISEASES; RESONANCE;

BRAIN ACTIVATION; BRAIN ATROPHY; CORTICAL REORGANIZATION; FINGER TAPPING; FUNCTIONAL MAGNETIC RESONANCE; GRAY MATTER; HEALTHY SUBJECTS; HIGH RESOLUTION; HUNTINGTON DISEASE; VOXEL-BASED MORPHOMETRY;

CHEMICAL ACTIVATION;

ADULT; AGED; ARTICLE; ATROPHY; BASAL GANGLION; BRAIN ATROPHY; CAPSULA INTERNA; CAUDATE NUCLEUS; CINGULATE GYRUS; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; HUNTINGTON CHOREA; IMAGING; INSULA; MALE; NORADRENALIN BRAIN LEVEL; OCCIPITAL LOBE; PRIORITY JOURNAL; SYMPTOMATOLOGY; TEMPORAL LOBE; THALAMOCORTICAL TRACT; THALAMUS; WHITE MATTER;

EID: 34648812766     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rct.0000284390.53202.2e     Document Type: Article

References (31)

1. Martin JB. Molecular basis of the neurodegenerative disorders. N Engl J Med. 1993;340:1970-1980.
2. Aylward EH, Sparks BF, Field KM, et al. Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology. 2004;63:66-72.
3. Kassubek J, Juengling FD, Kioschies T, et al. Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study. J Neurol Neurosurg Psychiatry. 2004;75:213-220.
4. Paulsen JS, Zimbelman JL, Hinton SC, et al. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's disease. AJNR Am J Neuroradiol. 2004;25:1715-1721.
5. Reading SAJ, Dziorny AC, Peroutka LA, et al. Functional brain changes in presymptomatic Huntington's disease. Ann Neurol. 2004;55:879-883.
6. Girotti F, Carella F, Scagliano G, et al. Effect of neuroleptic treatment on involuntary movements and motor performances in Huntington's disease. J Neurol Neurosurg Psychiatry. 1984;47:848-852.
7. Muglia M, Leone O, Annesi G, et al. Nonisotopic method for accurate detection of (CAG)n repeats causing Huntington disease. Clin Chem. 1996;42:1601-1603.
8. Rubinsztein DC, Leggo J, Coles R, et al. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet. 1996;59:16-22.
9. Shoulson I. Huntington disease: functional capacities in patients treated with neuroleptic and antidepressant drugs. Neurology. 1981;31:1333-1335.
10. Huntington Study Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord. 1996;11:136-142.
11. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1991;9:97-113.
12. Herndon RM. Handbook of Neurological Rating Scales. New York: Demos Vermande; 1997.
13. Rocca MA, Falini A, Colombo B, et al. Adaptive functional changes in the cerebral cortex of patients with non-disabling MS correlate with the extent of brain structural damage. Ann Neurol. 2002;51:330-339.
14. Good CD, Johnsrude IS, Ashburner J, et al. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage. 2001;14:21-36.
15. Ashburner J, Friston KJ. Voxel-based morphometry - the methods. Neuroimage. 2000;1:805-821.
16. Keller SS, Wilke M, Wieshmann UC, et al. Comparison of standard and optimized voxel-based morphometry for analysis of brain changes associated with temporal lobe epilepsy. Neuroimage. 2004;23:167-174.
17. Friston KJ, Holmes AP, Poline JB, et al. Analysis of fMRI time series revisited. Neuroimage. 1995;2:45-53.
18. Worsley KJ, Friston KJ. Analysis of fMRI time-series revisited again. Neuroimage. 1995;2:173-181.
19. Friston KJ, Holmes AP, Price CJ, et al. Multisubject fMRI studies and conjunction analysis. Neuroimage. 1999;10:385-396.
20. Halliday GM, McRitchie DA, Double KL, et al. Regional specificity of brain atrophy in Huntington's disease. Exp Neurol. 1998;154:663-672.
21. Rosas HD, Liu AK, Hersch S, et al. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology. 2002;58:695-701.
22. Reddy H, DeStefano N, Mortilla M, et al. Functional reorganization of motor cortex increases with greater axonal injury from CADASIL. Stroke. 2002;33:502-508.
23. Bartenstein P, Weindl A, Spiegel S, et al. Central motor processing in Huntington's disease. A PET study. Brain. 1997;120:1553-1567.
24. Blinkenberg M, Bonde C, Holm S, et al. Rate dependence of regional cerebral activation during performance of a repetitive motor task: a PET study. J Cereb Blood Flow Metab. 1996;16:794-803.
25. Sadato N, Ibanez V, Campbell G, et al. Frequency-dependent changes of regional cerebral blood flow during finger movements: functional MRI compared to PET. J Cereb Blood Flow Metab. 1997;17:670-679.
26. Weeks RA, Ceballos-Baumann A, Piccini P, et al. Cortical control of movement in Huntington's disease. A PET activation study. Brain. 1997;120:1569-1578.
27. Wenderoth N, Debaere F, Sunaert S, et al. Parieto-premotor areas mediate directional interference during bimanual movements. Cereb Cortex. 2004;14:1153-1163.
28. Thieben MJ, Duggins AJ, Good CD, et al. The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain. 2002;125:1815-1828.
29. Muller JL, Klein HE. Neuroleptic therapy influences basal ganglia activation: a functional magnetic resonance imaging study comparing controls to haloperidol- and olanzapine-treated inpatients. Psychiatry Clin Neurosci. 2000;54:653-658.
30. Loubinoux I, Tombari D, Patiente J, et al. Modulation of behaviour and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer. Neuroimage. 2005;27:299-313.
31. Morgan V, Pickens D, Gautman S, et al. Amitriptyline reduces rectal pain related activation of the anterior cingulated cortex in patients with irritable bowel syndrome. Gut. 2005;54:601-607.